Searchable abstracts of presentations at key conferences on calcified tissues

ba0004is9biog | (1) (1) | ICCBH2015

Upper limb deformity in osteogenesis imperfecta

Gdalevitch Marie

Biographical DetailsDr Marie Gdalevitch completed both her medical and orthopedic surgery degrees at McGill University. Following her residency, Dr M Gdalevitch pursued her first fellowship in limb lengthening and deformity correction at the International Center for Limb Lengthening in Baltimore, Maryland. Dr M Gdalevitch then embarked on her second fellowship in pediatric orthopedics and...

ba0001pp179 | Cell biology: osteoblasts and bone formation | ECTS2013

Mineralizing properties of DMP1 studied in vitro with cellular and acellular 3D collagen model systems mimicking the bone tissue

Silvent Jeremie , Nassif Nadine , Azais Thierry , Helary Christophe , Delgado Sidney , Soncin Fabrice , Giraud-Guille Marie Madeleine , Sire Jean-Yves

Bone is a complex structure associating cells to an extracellular organic phase, including collagen and non collagenous proteins (NCPs), in close association with apatite mineral platelets. Although bone has given rise to extensive studies, the exact part played by NCPs in nucleating or inhibiting the mineral phase remains controversial. The present study aimed to better understand the functions of a major mineralizing protein, dentin matrix phosphoprotein 1 (DMP1), an acidic,...

ba0003pp347 | Osteoporosis: treatment | ECTS2014

The efficacy of the treatment with intravenous ibandronate in common population.

Flanderova Marie

Objectives: To confirm effect of intravenous treatment with ibandronate every three months in common population of postmenopausal women.Methods: Patients with postmenopausal osteoporosis, who fulfil ACR criteria for postmenopausal osteoporosis and were treated with intravenous ibandronate for two years, underwent DEXA examination.Results: A 50 women suffering from postmenopausal osteoporosis were treated with ibandronate i.v. every...

ba0004is9 | (1) (1) | ICCBH2015

Upper limb deformity in osteogenesis imperfecta

Gdalevitch Marie

The objectives of this talk are to discuss the assessment, management, and operative indications of upper limb deformities in osteogenesis imperfecta (OI). The indications for operative treatment of upper limb deformities have evolved with the advent of improved medical treatment (bisphosphonates) and long bone rodding in the lower extremities. Long bone rodding in the lower extremities has become standard treatment in OI. However, upper limb deformities are less commonly trea...

ba0004oc19 | (1) | ICCBH2015

The VINE study: vitamin D in newborns: a randomized controlled trial comparing daily and bolus supplementation in breastfed infants of vitamin D deficient mothers

Huynh Julie , Lu Thao , Liew Danny , Doery James , Tudball Ronald , Jona Madeleine , Bhamjee Roisin , Rodda Christine

Objective: There is no published data to demonstrate the efficacy and safety of a single bolus dose vitamin D in breastfed infants of vitamin D deficient mothers. We evaluated the efficacy and safety of this alternative approach in newborn infants <4 months of age.Method: This single centre study was conducted from Aug 2013 to May 2014. Of 307 pregnant women diagnosed with vitamin D deficiency (25OHD<50 nmol/l) 70 were recruited. Their newborn in...

ba0006lb6 | (1) | ICCBH2017

Altered bone metabolism in Fanconi anemia results from defective mesenchymal stem cell differentiation

Mazon Melody , Julien Jacinthe , Ung Roth-Visal , Picard Sylvain , Bisson Sarah-Kim , Mac-Way Fabrice , Carreau Madeleine

Fanconi anemia (FA) is a rare genetic disease associated with a progressive decline in hematopoietic stem cells leading to bone marrow failure. FA is also characterized by various developmental defects including short stature and skeletal malformations of the upper and lower limbs. Indeed, more than half of children affected with FA have radial-ray abnormalities with a tendency to early osteoporosis and osteopenia. However, the underlying mechanisms leading to bone defects in ...

ba0001mtp6 | (1) | ECTS2013

Bone pain

Heegaard Anne-Marie

Bone pain is a common symptom of both malignant and non-malignant bone disease. Bone pain is often the first sign of metastatic spread in patients suffering from breast, lung or prostate cancer. Cancer-induced bone pain is one of the most difficult of all persistent pain states to fully control, and it severely affects the quality of life of the patients.Bone pain is also a common symptom of non-malignant metabolic bone diseases such as osteomalacia, fib...

ba0003cu2.5 | Management of parathyroid diseases | ECTS2014

Secondary and tertiary hyperparathyroidism

Lafage-Proust Marie-Helene

The pathophysiology of secondary hyperparathyroidism (II HPT) in the absence of renal disease is mainly due to lack of vitamin D, calcium deficiency being extremely rare. In case of chronic kidney disease (CKD), phosphate retention and increase in secretion of FGF23 by bone are among the earliest factors associated with II HPT occurrence. Then, the deficit in calcitriol synthesis induces lack of calcium intestinal absorption which worsens II HPT. As renal function declines, th...

ba0003w3.1 | Blood supply in pathophysiology of bone | ECTS2014

Functional role of blood vessels in bone

Proust Marie-Helene Lafage

Blood vessels and bone display spatial and functional relationships. While the coupling of angiogenesis to bone formation during modeling situations is well documented, the vessels roles in bone remodeling, although widely acknowledged, remain poorly explored. In order to image and quantify the bone vessel network in rodents, we contrasted the vascular bed with barium sulfate, followed by histology or either conventional or synchrotron radiation micro-computed tomography. We s...

ba0006p134 | (1) | ICCBH2017

Improvement in spinal involvement with zoledronic acid in pediatric patients with chronic recurrent multifocal osteomyelitis: a case series

Robinson Marie-Eve , Sbrocchi Anne Marie , Scuccimarri Rosie

Background: Chronic recurrent multifocal osteomyelitis (CRMO) is a rare inflammatory bone disease characterized by chronic non-infectious osteomyelitis. Spinal involvement has been reported in up to 26% of patients (1). Three studies evaluated the effect of Pamidronate (PAM) on spinal lesions in pediatric patients with CRMO (1, 2, 3) and showed partial or complete resolution of vertebral hyperintensities on MRI (1). However, the effect of Zoledronic acid (ZOL) in pediatric pat...